CRSP 股东权益历史(2016–2025)
CRISPR THERAPEUTICS AG (CRSP) 各财年年末股东权益(来自 SEC 财报)。
$1.9BFY2025 · FY2016 以来:$232.8M → $1.9B
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $1.9B | -0.5% |
| FY2024 | $1.9B | +2.6% |
| FY2023 | $1.9B | +0.4% |
| FY2022 | $1.9B | -21.8% |
| FY2021 | $2.4B | +44.2% |
| FY2020 | $1.7B | +77.2% |
| FY2019 | $939.4M | +139.5% |
| FY2018 | $392.2M | +108.8% |
| FY2017 | $187.8M | -19.3% |
| FY2016 | $232.8M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议